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OBSERVATIONS RELATED TO PATHOGENESIS OF DENGUE HEMORRHAGIC FEVER.
1. EXPERIENCE WITH CLASSIFICATION OF DENGUE VIRUSESt
Two distinct syndromes associated with dengue virus infection are preva-
lent in tropical Asia; dengue fever, a benign disease characterized by fever,
myalgia, leucopenia and a maculo-papular rash and dengue hemorrhagic
fever (DHF), accompanied by fever, shock, hemorrhagic diathesis and a
significant mortality.1 The dengue viruses, a group of antigenically related
members of the Group B arthropod-borne virus family, are transmitted
from man to man by the mosquito, Aedes aegypti. Multiple members of the
group are known to be simultaneously transmitted in large urban areas of
tropical Asia. Dengue disease syndromes of both types may occur concur-
rently, DHF usually is restricted to the indigenous population, while
dengue fever may occur in both indigenous and non-indigenous residents
of an area."
When dengue hemorrhagic fever was first described in the Philippines,
two new dengue viruses, types 3 and 4 were recovered from patients.'
Shortly thereafter, dengue strains recovered from DHF patients in Thai-
land were tentatively designated types 5 and 6.5 As one explanation of the
malignant type of dengue fever, it was suggested that dengue viruses had
acquired virulence properties.6 A corollary to this hypothesis was that
virulence and surface antigen were genetically linked and thus, the "newer"
types of dengue viruses were the cause of the severe dengue syndrome.
The hypothesis that DHF is due to a self-destructive host response has
been proposed by Halstead and associates.7 They suggested that some per-
sons are sensitized by their first dengue infection. In such a host the course
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of a second infection with a virus of a different type may be altered ad-
versely by an immune response. The following kinds of evidence support
this hypothesis: a) almost all patients with severe hemorrhagic fever
(dengue shock syndrome) exhibit a secondary (IgG) dengue antibody
response; b) the dengue shock syndrome occurs only in areas of tropical
Asia where two or more types of dengue viruses are simultaneously or
sequentially endemic; c) no single strain of dengue virus has been associ-
ated with dengue shock syndrome, at least four types having been isolated
from patients; d) at most, one dengue virus has been isolated from a single
patient, suggesting that symptoms are precipitated by a single infection,
and e) the shock syndrome is not seen in short term residents of dengue
endemic areas who, if infected, have primary but only rarely, secondary
dengue infections.
This series of communications"8 extends our preliminary reports on
dengue infections in man and summarizes extensive observations both on
dengue viruses and the dengue infected host which appear to be related to
pathogenetic mechanisms operating in this system.
The following paper presents an antigenic analysis of dengue virus strains
and attempts to correlate these with the disease response in the host.8 Paper
III summarizes investigations on a series of fatal hemorrhagic fever cases.9
The fourth paper analyses severity of host response by the type of antibody
response and the type of dengue virus recovered.'0 The fifth employs a
mathematical model to analyze sequential infection phenomena and com-
pares data derived with observed hemorrhagic fever hospitalization rates
in Bangkok." The final paper discusses pertinent observations and proposes
general hypotheses of the pathogenesis of dengue and DHF."
This paper summarizes a variety of observations made during the course
of identifying nearly 300 dengue virus strains recovered in several host
systems in 1962-1964. Details of a highly successful single-overlay dengue
plaque assay and a plaque reduction neutralization test that uses micro-
quantities of reagents are included. Comparative observations on virus
identification attempts by several methods are presented and the relation
of these results to the question of whether the viruses isolated during this
period differed from prototype dengue virus types 14 are considered. Some
of the techniques evolved during this experience have been described.'"'
MATERIALS AND METHODS
Viruses. Thailand viruses were recovered in suckling mice or tissue culture by
methods described previously.' Attempts were made to keep laboratory host passage
of virus strains as low as possible. Between January, 1962 and January, 1965, 45
dengue-like viruses were recovered from arthropods and 250 dengue-like viruses were
recovered from human beings with various febrile illnesses. On initial recovery attempt,
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140 were recovered in suckling mice, 145 in BS-C-1 (continuous grivet monkey kid-
ney) cells, and 23 strains were recovered in both host systems.
Three different sets of prototype dengue viruses were employed: A. Dengue 1
(Hawaii) at 70th suckling mouse passage (smp), dengue 2 (TR 1751) at 70th smp,
dengue 3 (H-87) at 36th smp, dengue 4 (H-241) at 36th smp, TH-36 at 17th smp
and TH-Sman, 17th smp. These viruses were received in Thailand in 1960 or 1961,
probably from the laboratory of Dr. W. McD. Hammon. B. Dengue 1 (Hawaii) at
124th smp, dengue 2 (New Guinea C) 25th smp, dengue 3 (H-87) 20th smp, dengue
4 (H-241) 24th smp, TH-36, 13th smp, and TH-Sman, 12th smp; each of these strains
had been cloned by three terminal dilutions in mice in Hammon's laboratory.' C.
Dengue 1 (Hawaii) 70th smp, dengue 2 (TR 1751) 70th smp, dengue 3 (H-87) 23rd
smp, dengue 4 (H-241) 15th smp, TH-36 15th smp and TH-Sman 15th smp. These
were in the collection of arthropod-borne viruses at the Yale Arbovirus Research Unit
having been received a varying number of years previously from laboratories in which
the strains were originally isolated.
Antigens. Acetone-ether extracted mouse brain virus antigens prepared by the
method of Clarke and Casals'6 were used for both hemagglutination-inhibition and
complement-fixation tests.
Hemagglutination-inhibition (HI) test. HI tests were performed by the method of
Clarke and Casals'6 with the modification for Microtiter equipment. Eight units of
hemagglutinin of each virus antigen were used in the tests reported. The temperature
of incubation of virus-cell mixtures was 220C. The HI titer is expressed as the last
dilution at which a complete inhibition of hemagglutination occurred.
Complement fixation (CF) test. Complement-fixation tests were done by the method
described by Fulton and Dumbell" modified for Microtiter equipment. Two exact units
of complement and three minimal hemolytic doses of antisheep hemolysin were used
in all tests. Serum and saline controls and known positive and negative sera were in-
cluded in each test.
Immune Serum. Mouse immune sera. Technique 1. Suckling mice were inoculated
intracerebrally (IC) with dengue seed virus. After mice became sick, a 10% suspen-
sion of mouse brain was prepared in normal saline. This suspension was inoculated
immediately into 21-42 day old mice intraperitoneally (IP) in 0.2 ml. amounts. Five
or more injections of fresh mouse brain-saline suspensions were inoculated at one week
intervals. Trial bleedings were made to determine when satisfactory antibody titer had
been obtained.
Technique 2. Three-to-four-week-old mice were inoculated IP with 0.3 ml. of 10%
fresh mouse brain in saline harvested from mice infected with unidentified viruses at
low mouse passage. Two weeks later mice were inoculated with 0.03 ml. of 102
virus suspension intracerebrally. A trial bleeding was performed 10 days later. If titer
was not satisfactory new groups of weanling mice were immunized using a second
schedule. First, 0.3 ml. of 10-' virus suspension was inoculated IP; 10 days later 0.1
ml. of 10' virus suspension was given IP and subcutaneously. Ten days later, 0.03 ml.
of 10-1 virus suspension was injected into mice intracerebrally. Trial bleeding was
made two weeks later.*
Monkey antiserum. Young adult Macaca mulatta free of group B hemagglutination-
inhibition antibodies and plaque reduction antibody to denggue types 1-4 were inocu-
* The principals of laboratory animal care as promulgated by the National Society
for Medical Research were observed.
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lated subcutaneously with 0.5 ml. of a 1:10 dilution of virus in 0.75% bovine albumin
in phosphate buffered saline (BAPS). Virus was prepared by homogenizing a sus-
pension of infected LLC-MK2 (continuous rhesus kidney) cell monolayers harvested
on the sixth day after virus inoculation. Monkeys were bled six weeks or more after
infection.
Tissue culture neutralization test. The property of BS-C-1 cells infected with dengue
viruses to resist challenge with a cytopathic virus has been described.' Tube cultures
of these cells were used to test for dengue neutralization antibodies using the virus
dilution, serum-constant method. Virus-serum mixtures were incubated at 370C. for
one hour. Equal amounts of normal mouse serum and virus dilutions were incubated
similarly for estimation of virus titer. Chikungunya virus was used as a cytopathic
challenge virus to test for dengue virus-induced cellular resistance. Results are ex-
pressed as log neutralization index (LNI). LNI of 1.7 or greater was considered
significant neutralization.
Plaque reduction neutralization test. A preliminary communication has described
the LLC-MK2 dengue virus plaque assay.' A strain of LLC-MK2 propagated at Yale
University School of Medicine for an unknown period was used in these studies. Test
conditions and techniques for propagation of cells differed somewhat from those re-
ported earlier. Cells were grown in a medium consisting of Eagle's Basal Medium, 5%
agamma calf serum, 5% calf serum, final concentrations of glutamine of 200 mM per
ml., bicarbonate of 0.45 mg/ml. and penicillin and streptomycin, of 100 units and 100
mg/ml., respectively. Seven days after inoculation of 2 oz. plaque bottles with 7 ml.
containing 120,000 cells/ml., monolayers were ready to use. Virus was diluted either in
0.75% BAPS, 20% agamma calf serum in phosphate buffered saline, pH 7.8-8.0
(PBS), or acetone extracted normal mouse ascitic fluid in PBS. After incubation un-
der conditions described in the text, neutralization reaction in virus-serum mixture was
stopped by one hundred-fold dilution in chilled diluent. Growth medium was poured
off cell sheet and 0.5 ml. of the diluted virus-serum mixture added without washing
cells. Tubes were then incubated at 370C. for 90 minutes, next, virus inoculum was
removed and in a darkened room, agar overlay added. Agar overlay contained a final
concentration of 1:10,000 (millipore filtered) neutral red and 1%o Noble agar; con-
centrations of other ingredients were identical to those in growth medium except that
one half concentration of bicarbonate was used. The pH of agar overlay was approxi-
mately 7.9. Plaque bottles were held at 35-36°C. for 7 days and then for two weeks at
room temperature. All incident light was excluded during the period. Plaques continue
to appear and enlarge for many days, necessitating readings at 7, 14, and 21 days.
Plaque reduction serum titers (50% end point) were estimated by the method of
Russell, et al.'8
RESULTS
The earliest method employed for identification of dengue viruses was a
virus dilution, serum constant neutralization test performed in BS-C-1 cells
using the CVR method.'8 Mouse antisera to prototype dengue viruses were
prepared by technique 1. Table 1 shows a grid-type comparison of proto-
type dengue 1-4, TH-36 and TH-Sman virus strains (group A) and anti-
sera. Although some degree of crossing was observed, most lots of serum
were relatively specific to homologous virus. Significant cross neutralization
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TABLE 1. CRoss NEUTRALIZATION TESTS OF DENGUE 1-4, TH-36 AND TH-SMAN
VIRUSES IN BS-C-1 CELLS
Log neutralization index of indicated viruses and antisera
Antiserum I Virus dl d2 d3 d4 TH-36 TH-Sman
dl 3.0 1.0 1.2 0.5 1.0 2.5
d2 1.0 3.0 0.8 0.7 3.0 1.2
d3 1.5 1.0 2.0 0.5 0.8 1.0
d4 0.5 0.5 0.0 4.0 0.9 0.5
TH-36 1.0 3.5 0.7 1.0 2.5 0.3
TH-Sman 2.0 1.2 1.5 0.3 0.8 3.4
d = dengue.
was observed between dengue 1 and TH-Sman and dengue 2 and TH-36
viruses and antisera. Less significant neutralization was noted between
dengue 1 and 3 viruses. During three years of preparation of hyperimmune
mouse serum many lots of dengue 3 and 4 antisera failed to neutralize sig-
nificantly homologous virus. It was found that use of frozen virus-brain
seeds was not as suitable as fresh material in producing a good antibody
response in mice.
Table 2 illustrates the results of attempted identification of the 121
dengue viruses recovered in suckling mice. Of the total tested, 71 viruses
were neutralized significantly by one or more antisera. Of 50 viruses neu-
tralized either by dengue 2 or TH-36 antiserum, 23 were significantly
TABLE 2. SUMMARY OF ATTEMPTED IDENTIFICATION OF 121 SUCKLING MOUSE
ADAPTED VIRUSES. VIRUS ISOLATES WERE TESTED AGAINST HYPERIMMUNE SERUM
TO DENGUE 1-4, TH-36 AND TH-SMAN BY A NEUTRALIZATION TEST
IN BS-C-1 CELLS
No. isolates neutralized No. isolates
significantly by not neutralized Low or no Results con-
indicated antisera by sera virus titer tradictory
dl 7
TH-Sman 3
dl + TH-Sman 3
d2 4
TH-36 13
d2 + TH-36 33
d3 7
d4 1
Total 71 28 18 4
d = dengue.
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neutralized by both. Only 3 of 13 viruses in the dengue 1-TH-Sman group
were neutralized by both antisera. Significant neutralization by more than
one dengue antiserum (types 1-4) was observed with four viruses. Identi-
fication could not be established in these instances. Twenty-eight viruses
were not significantly neutralized by any of six dengue antisera. To cope
with these viruses, other identification methods were investigated.
Preparation of immune serum to isolates. Hyperimmune sera prepared
by technique 1 to low mouse passage isolates were tested by HI and CF.
Representative results are shown in Tables 3 and 4. By HI, hyperimmune
TABLE 3. IDENTIFICATION OF DENGUE VIRUSES. HEMAGGLUTINATION-INHIBITION
TEST OF ANTISERA PREPARED TO ISOLATES
Bangkok irus Reciprocal of antibody titer vs. indicated dengue antigens
mouse immune
serum dl d2 d3 d4 TH-36 TH-Sman Homol.
2358-62 40 160 40 80 160 80 160
3149-62 80 40 80 80 80 160 320
5031-62 160 160 80 160 80 320 320
BKM-60-62 80 320 80 160 640 80 1,280
BKM-331-62 40 40 160 80 20 20 160
BKM-418-62 160 640 40 80 160 80 320
Homol. = Homologous antigen.
TABLE 4. IDENTIFICATION OF DENGUE VIRUSES. COMPLEMENT-FIXATION TEST OF
HYPERIMMUNE SERUM PREPARED TO ISOLATES BY TECHNIQUE I.
Reciprocal of CF antibody titer vs. two units of indicated
Bangkok p irus prototype dengue antigen
hyperimmune
serum Homologous
dl d2 d3 d4 TH-36 TH-Sman virus
2358-62 4* 32 0** 4 4 4 64/128t
3149-62 16 8 8 4 4 16 16/32
5031-62 16 4 4 4 8 8 16/32
BKM-60-62 0 16 0 0 8 0 16/32
BKM-331-62 16 8 64 8 0 8 32/32
BKM-418-62 16 32 16 8 32 0 64/128
BKM-475-62 16 0 0 0 0 8 8/16
* Signifies reciprocal of highest dilution of serum which gives 2+ or more fixation
of complement.
** No fixation at 1 :4 dilution of serum.
t The numerator represents the maximum dilution of serum fixing complement in
the presence of antigen and the denominator the maximum dilution of an antigen fixing
complement in the presence of antiserum.
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serum titers to each of six prototype antigens varied from each other by
two-to fourfold. Highest titers to prototype antigens often were within two-
fold of titers to homologous virus. Results by CF were sometimes quite
specific. Usually there was a marked similarity in serum titers with dengue
1 and TH-Sman or dengue 2 and TH-36 antigens, respectively. In some
instances, CF titers to two or more antigens (dl-4) differed by at most
only twofold, making test results difficult to interpret. For this reason, a
modification in the antiserum preparation method was introduced. Table 5
TABLE 5. IDENTIFICATION OF DENGUE VIRUSES. COMPLEMENT-FIXATION TEST
USING IMMUNE SERUM PREPARED BY Two INOCULATIONS OF INDICATED
ISOLATES (TECHNIQUE II)
Reciprocal of antibody titer vs. tzvo units of
Immune mouse indicated prototype dengue antigett
serum
dl d2 d3 d4 TH-36 TH-Sman
2358-62 0* 32 0 0 16 0
3149-62 16 0 0 0 0 8
5031-62 4 0 0 0 0 8
BKM-60-62 0 8 0 0 8 0
BKM-331-62 0 0 16 0 0 0
BKM-418-62 0 4 0 0 4 0
* No fixation at a 1:4 serum dilution.
shows representative CF results obtained with mouse antiserum prepared
by technique 2. In this system little heterologous reaction was observed.
There was a consistently close correlation between serum titers to dengue 1
or TH-Sman and dengue 2 or TH-36 antigens, respectively. Results are
illustrated in Tables 6 and 7.
TABLE 6. CORRELATION TABLE SHOWING CF ANTIBODY TITERS OF 26 BANGKOK







Reciprocal titer vs. two units
of dengue 1 (Hawaii) antigen
Reciprocal
CF titer <4 4 8 16 32
<4 1
4 2 2
8 4 5 1
16 2 4 1
32 1 1 2
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TABLE 7. CORRELATION TABLE SHOWING CF ANTIBODY TITERS IN 44 BANGKOK
DENGUE VIRUS MOUSE IMMUNE SERA TO DENGUE 2 (NEW GUINEA C) AND TH-36
Reciprocal titer vs. two units of dengue 2







CF titer <4 4 8 16 32
<4 1 2 3
4 3 3 1
8 3 1 4 4 2
16 2 4 5
32 1 1 3
A good correspondence was observed between results in the neutraliza-
tion test and the CF test of serum prepared to isolates (Table 8). The CF
identification results obtained for the 50 viruses for which contradictory
neutralization indices or no neutralization occurred are not shown. Of 28
strains to which detectable dengue antibodies developed in mice, 21 fixed
complement only with dengue 3 virus. Of the 28 viruses not significantly
neutralized by any prototype dengue antiserum, 14 were subsequently
identified as dengue 3. It appeared that many "wild" dengue 3 strains were
poorly neutralized by antiserum prepared to H-87 strain of dengue 3 virus.
From August, 1963, BS-C-1 cells were used for the majority of dengue
virus isolation attempts. Tissue culture passage viruses brought new prob-
lems in identification. While the neutralization test employing mouse hyper-
immune serum could be used, the percentage of untyped viruses was about
the same as reported above. Attempts to produce immune or hyperimmune
serum by IP and IC challenge in mice to tissue culture viruses failed in
most instances. An exception to this observation occurred with the dengue
2-TH 36 complex viruses, which did stimulate antibody production in mice.
As evidence of their low pathogenicity, undiluted tissue culture viruses
rarely resulted in sickness or death following intracerebral inoculation of
TABLE 8. COMPARATIVE RESULTS BETWEEN COMPLEMENT-FIXATION* AND
NEUTRALIZATION** TECHNIQUES FOR IDENTIFICATION OF DENGUE VIRUS ISOLATES
Total viruses! identified by Nt = 71
CF results identical to Ntt = 59
CF results different 7
No CF antibody detected = 5
* Mouse immune serum prepared by two or three injections of dengue virus antigens.
** Low mouse passage dengue virus isolates tested against hyperimmune (five anti-
gen injections) dengue prototype mouse serum in BS-C-1 cells.
t Considered identical if Nt results were positive for dl and/or TH-Sman and CF
results positive for both dl and TH-Sman. Same conditions apply for d2-TH-36.
268
Volume 42, April, 1970| HALSTEAD, et al.
weanling mice. A process of blind intracerebral passage of viruses in suck-
ling mice, similar to that used to recover dengue viruses from human serum,
had to be employed to adapt tissue culture passage strains to mice. For a
large number of tissue culture viruses this was done and antiserum prepared
in mice and virus identified as described above.
Plaque reduction test. The inadequacies apparent in each of the identifi-
cation systems described led to a search for a more discriminating and yet
versatile technique. A plaque reduction test using the LLC-MK2 plaque
assay system fulfilled these criteria. Studies of the neutralization character-
istics of Macaca irus immune serum by some of us had led to a highly re-
producible dengue virus identification technique applicable to virus from
any host.'8 In the Yale laboratory these results have been extended to anti-
sera prepared in Macaca mulatta. There appears to be an important advan-
tage in using the latter species. More than 80 young adults of this species,
purchased in four separate lots in 1966-1967, have been found to be free of
neutralizing antibody to dengue types 1-4 viruses. Sera from 16/20 Macaca
irus of unknown geographic origin, obtained in 1967, contained high titered
plaque reducing antibodies to dengue 1 and/or dengue 2 viruses.
Cross neutralization tests between dengue types 1-4 and TH-36 and TH-
Sman strains using monkey antisera are illustrated in Table 9. Also in-
cluded are neutralization data for dengue strain 13711 isolated from a
hemorrhagic fever patient in the 1964 Ubol, Thailand outbreak.' These
data show nearly identical 50 percent serum plaque reduction titers between
dengue 1, TH-Sman and 13711 viruses and antisera and between dengue 2
and TH-36 viruses and antisera, respectively. Table 10 shows further ap-
plication of Macaca mzulatta antisera to the typing of tissue culture adapted
dengue strains. It was of interest that 1950-63 dengue strain was poorly
neutralized by homologous as well as two different heterologous dengue 2
immune sera. In contrast, the antibody produced in two monkeys following
infection with 1950-63 strain was nearly equal in titer to that produced by
animals infected with 16681 dengue 2 strain.
Of 22 viruses not identified by any other technique, 17 were typed by
plaque reduction neutralization test (courtesy of P. K. Russell). Only five
virus strains were untyped. These were dengue-like in their biologic be-
havior, but after 1966 no further identification attempts could be made and
the strains are now lost. Of all the 295 dengue-like agents, 207 were identi-
fied in two or more systems.
DISCUSSION
Several important observations were made: (1.) Using as assay system
fluid-covered cell monolayers, neutralization of some dengue viruses by
269
Classification ofdengueYALE JOURNAL OF BIOLOGY AND MEDICINE Volume 42, April, 1970
o~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c
Z ~~~~~~~~ ~ ~ ~ ) %C) CD -n
0~~~~~~~~~~~~~~
r4)Y4 0) 0in 0 C0
0
T--4~~~~~~~~~~~~~~~~~~~~~-
~~ ~i-'0 (NJ ~~v vN vN
C.7 ~~~~~~~~~~~~0
~~) 04 z o0 0 0 0 0 0 0 C C C C>
~~ ~. )~~0~~ (Ni (NJ3 U)n ( (NJ4 (NJ (N %J 0 ~~~~~~v V V V V V
bo c a
0 0n C's0 ~ 0 )
U)~ ~ ~ z C> C Coi4 i
o ~~~~~i
- V V V V
z cd
Z~~~ 0 (NJ ~ ~ ~ ~ ~ C





270Classification of dengue I HALSTEAD, et al.
o in U 0 0 0 0 Q
1- eM U'i - W- r V- 8 V V V VV
V VV VVVA A vv V
o o 00 o 0 0 u 0
-M O~. _ - - '0 d -
V V V V
O d00 0 M O 0 u r 0 ~~~~v vV
V~ 0 0u V 0V
4'9> C)s
oo o t o" -
X N _ en _ __v
~~V ~~~ V VV~>
a~~~~~~~~~~~V o oo
von _l _ W _ _ _ v
A V A ~~~~~~V V V
ooo v
































































e liYALE JOURNAL OF BIOLOGY AND MEDICINE
hyperimmune mouse serum was either reversible or incomplete. This was
frequently observed with strains of dengue 3 virus. Whether this is due to
dissociation of virus-antibody complex, incomplete neutralization, lack of
accessory factor(s), competition between cell and antibody for virus or other
phenomena requires study. Dengue 2 viruses, on the other hand, quite regu-
larly stimulated production of antibody in the mouse which could neutralize
50 or more InD50 of homologous virus in this assay system.
(2.) When a course of only two or three antigenic stimuli with low mouse
passage Thailand dengue viruses was used for antibody production in the
mouse, resultant sera when tested by CF had titers to dengue 1 and TH-
Sman or dengue 2 and TH-36 antigens which were closely similar. Al-
though this identification system was useful for mouse passaged material it
was of little value in identifying tissue culture passage viruses because of
their low virulence and/or low immunogenicity for mice.
(3.) Dengue infection in susceptible monkeys from a single subcutaneous
inoculation of live virus resulted in production of neutralizing antibody
which, in a 50%o plaque reduction end point test, had a high titer to
the homologous virus and one of the dengue 1-4 prototypes. Immune mon-
key sera did not appear to distinguish between dengue 1 and TH-Sman or
dengue 2 and TH-36 viruses. It was noted that two strains of tissue culture
passage dengue type 2 differed in their neutralization properties with three
dengue 2 antisera. A reason for the poor neutralization observed with the
1950-63 dengue strain might be that a large portion of this virus population
exists in aggregates that break down and liberate virus under the agar
overlay.
(4.) A virus-dilution serum-constant neutralization test using dengue
mouse immune serum indicated antigenic dissimilarity between the Hawaii
and TH-Sman dengue 1 strains and between New Guinea C and TH-36
dengue 2 strains but two other test systems (complement fixation test of
mouse dengue immune sera to Thailand isolates and plaque reduction neu-
tralization test using serum obtained from infected monkeys) suggested that
these two pairs of viruses are closely identical. These observations are
similar to conclusions obtained in an immuno-electrophoretic study of
dengue viruses,'9 and an analysis of dengue viruses by plaque reduction
using monkey immune serum.'8
No viruses were recovered from patients or mosquitoes in Thailand from
1962-4 that consistently resembled TH-36 or TH-Sman in more than one
identification system. Evidence obtained in the virus dilution neutralization
test in BS-C-1 cells supporting the antigenic distinctness of these viruses
from dengue 2 and 1, respectively, must be qualified. Results obtained in
this system were not always reproducible; further, many lots of immune
272
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sera neutralized dengue viruses only poorly, or at threshold LNI values.
We believe the variations observed may result from poorly understood
factors that influence the completeness or reversibility of antibody-virus
complexing. These factors could be extraneous to the antigenic composition
of studied virus strains.
In a separate study we present results from an antigenic analysis of a
large number of dengue strains.8 These studies suggest that the antigenic
composition of dengue virus strains of the same type do differ. It is quite
apparent that in some systems dengue viruses are poorly neutralized by
antibody. Under these circumstances, immune sera containing antibodies to
the greatest percentage of the antigenic mosaic of a test strain may neu-
tralize that virus better than another virus with a less complete spectrum
of antigenic sites. Does this imply that these strains are different enough to
produce sequential infection in the same individual (i.e., are they different
types) ? We believe not. Based upon antibody responses to infection, the
monkey and the human2 distinguish in dengue viruses a major antigenic
determinant of which there are, apparently, only four. At this stage in the
technology of arboviruses, the most biologically relevant answer to the
question of how many distinct dengue types there are might be derived from
cross protection studies in susceptible hosts and not from in vitro antigenic
analyses; dengue cross protection studies in primates are in progress in our
laboratory.
SUMMARY
Two syndromes, a severe and sometimes fatal hemorrhagic fever
(DHF), and benign dengue fever (DF), are associated with dengue in-
fection in the human being. This series of papers describes studies of the
properties of dengue viruses and aspects of the disease response in the host
in an attempt to explain why these divergent syndromes occur. It has been
postulated that virulent dengue disease is associated with infection by
dengue types 3 and 4 and proposed types 5 and 6, while classic dengue
fever is caused by types 1 and 2. This paper, the largest experience re-
ported to date, summarizes comparative results obtained in typing 295
dengue viruses recovered from arthropods, DHF and DF cases in Thai-
land during a 3-year period, 1962-64. When dengue isolates were neu-
tralized by antisera prepared in mice to prototype dengue types 1-4, TH 36
(type 5?) and TH-Sman (type 6?), and assayed in a continuous grivet
monkey kidney cell tube test, some more nearly resembled the latter two
Thai strains than dengue types 1-4. When antibodies to dengue isolates
were produced in mice by a small number of antigenic stimuli, when tested
by complement fixation, these reacted with only one of the four prototype
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dengue antigens; TH-Sman and TH-36 antigens produced the same titers
as dengue types 1 and 2, respectively. Similar results were obtained when
isolates were neutralized by prototype dengue immune sera made in
monkeys and assayed in a plaque reduction neutralization test. The latter
two identification methods were more reproducible than the former. These
data support classification of the studied dengue viruses into four, not six,
types and are not compatible with the hypothesis that associates DHF
with "newer" dengue virus types. Commercially purchased North Indian
Macaca mulatta were found to be satisfactory for production of specific
dengue typing antisera. A single agar overlay dengue plaque assay in LLC
MK2 cells and a dengue plaque reduction neutralization test that utilizes
microquantities of serum are described.
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